Open-label, single-arm, phase 2 trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advanced biliary tract cancer
作者
Jeesun Yoon,Beodeul KANG,Se Jun Park,Ji‐Won Kim,Hye Jin Choi,Myung Ah Lee,Tae Yong Kim,Do‐Youn Oh